Comparison the IVF outcome in Methyl Testosterone consumers with placebo group in women with poor ovarian response referring to Yas infertility center

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20091012002576N16

Enrollment

120

Registered

2018-06-17

Start date

2018-06-10

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Poor responder in IVF. Female infertility

Interventions

Intervention 1: Intervention group: sixty patients include in the case group and use tablet methyletestesteron 25 mg, 1 daily, for 2 months before IVF cycle. Intervention 2: Control group: Sixty pat

Eligibility

Sex/Gender

Female

Age

35 Years to 42 Years

Inclusion criteria

Inclusion criteria: The number of oocytes punctured from them in previous cycles was less than or equal to 3 Antral follicle count less than 5 AMH less than 1.2

Exclusion criteria

Exclusion criteria: The history of ovarian surgery Systemic disease abnormal profiles of the blood sugar, cholesterol or triglyceride Thyroid disorders Renal dysfunction Liver Dysfunction

Design outcomes

Primary

Measure	Time frame
Number of oocyte retrieved. Timepoint: In the day of oocyte puncture. Method of measurement: Number of oocyte retrieved.	—

Secondary

Measure	Time frame
Number of embryo. Timepoint: Day 3 after injection. Method of measurement: Number of embryo.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Davari Tanha

Tehran University of Medical Sciences

fatedavtanha@gmail.com+98 21 8880 0611

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026